| 카탈로그 번호 | HB996026 |
| 숙주 종 | Humanized |
| 종 반응성 | Human |
| 형태 | Liquid |
| 저장 완충액 | 0.01M PBS, pH 7.4. |
| 순도 | >95% purity as determined by SDS-PAGE. |
| 클론성 | Monoclonal |
| 이소타입 | IgG1-kappa |
| 응용 분야 | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| 타겟 | CD19, Differentiation antigen CD19, T-cell surface antigen Leu-12, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4 |
| 정제 | Protein A/G purified from cell culture supernatant. |
| 내독소 수준 | Please contact the lab for this information. |
| 발현 시스템 | Mammalian Cells |
| 등록번호 | P15391 |
| 안정성 및 저장 | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Alternative name | CD19, MEDI-551, 1299440-37-1 |
| 참고사항 | For research use only. Not suitable for clinical or therapeutic use. |
Research Grade Inebilizumab
개요
설명
Inebilizumab (HB996026) is a research-grade recombinant antibody targeting CD19. Produced in mammalian cells with native-like glycosylation.
Highlights
- ●Research Grade — For PK/PD studies, assay development, and ADA research.
- ●Native Glycosylation — Mammalian expression ensures native-like patterns.
이미지
